De Novo Drug Design on JNK3+QED alpha=0.05
100Observed Coverage
Unweighted
Updated 1mo ago
Evaluation Results
| Method | Links | |
|---|---|---|
2023.10 | 100 | |
2023.10 | 98 | |
2023.10 | 98 | |
2023.10 | 94 | |
2023.10 | 93 | |
2023.10 | 92 | |
2023.10 | 89 | |
2023.10 | 83 |
Unweighted
| Method | Links | |
|---|---|---|
2023.10 | 100 | |
2023.10 | 98 | |
2023.10 | 98 | |
2023.10 | 94 | |
2023.10 | 93 | |
2023.10 | 92 | |
2023.10 | 89 | |
2023.10 | 83 |